InvestorsHub Logo

exwannabe

05/10/24 1:37 PM

#690360 RE: CaptainObvious #690358

Yes, one can have additional trials as backups.

BP's do this all the time. Ask Flipper about what he thinks of multiplicty on all the CI P3s :-)

Money does matter.

Nemesis18

05/10/24 2:25 PM

#690371 RE: CaptainObvious #690358

Yes but does not NWBO just have the leasing rights of DCVAX-l as a stand-alone treatment only.

Why would any combo-iteration equate to any added value to NWBO’s SP ?

UCL sure as hell aren’t going to share the research limelight or any future income with Northwest Therapeutics, are they. And why would they ?

Advent may pick up some third party manufacturing work from UCL for the European markets down the line, but again, NWBO is out of the income loop, in this aspect also,isn’t it ?

If I’m wrong, I’m happy to be corrected